Concepedia

Shilpa Shahani

SS

Statistics

Publications

11

Citations

1.1K

H-Index

10

Active since

2005

Affiliations

Stanford University(Current)

National Cancer Institute

National Institutes of Health

Center for Cancer Research

City Of Hope National Medical Center

Shilpa Shahani is an author at Stanford University specializing in immunotherapy, oncology, and medicine.

Publications per year

2005–2023

11

Publications

11

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten et al. · New England Journal of Medicine · 2023 · 410 citations · Full text

, , +17

Biodegradable and photocrosslinkable polyphosphoester hydrogel

Qiang Li, Jun Wang, Shilpa Shahani et al. · Biomaterials · 2005 · 186 citations

, , +12

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Haneen Shalabi, Haiying Qin, Angela Su et al. · Blood · 2022 · 175 citations · Full text

, , +17

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Erin F. Simonds, Edbert D Lu, O. Badillo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 112 citations · Full text

, , +17

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma

Soheila Shirinbak, Randall Y. Chan, Shilpa Shahani et al. · OncoImmunology · 2021 · 37 citations · Full text

, , +17

1–5 of 11